Related Experiment Video
Updated: Aug 26, 2026
Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
Published on: May 10, 2024
Single-atom Pt-N-C nanozyme targets Rara/Wnt/β-catenin axis for diabetic cardiomyopathy treatment
1Department of Cardiovascular Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Background And Purpose:
Diabetic cardiomyopathy (DCM) lacks effective therapies because of complex mechanisms. This study aims to develop a single-atom nanozyme for integrated antioxidant and signalling regulation in DCM.
Experimental Approach:
A graphene quantum dot-templated single-atom Pt-N-C nanozyme (PtsaN-C) was synthesised for all-trans retinoic acid (ATRA) delivery (PtsaN-C@ATRA). In vitro antioxidant activity and in vivo efficacy were evaluated in DCM mice, combined with scRNA-seq for mechanistic analysis.
Key Results:
PtsaN-C@ATRA improved cardiac function, reduced fibrosis/apoptosis and activated the Rara/Wnt/β-catenin axis to promote cardiomyocyte differentiation.
Conclusions And Implications:
PtsaN-C@ATRA represents a novel strategy merging nanozyme catalysis with transcriptional regulation, offering potential for clinical translation in DCM.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
01:23Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...